First-in-class immune-stimulating antibody conjugate BDC-4182 Phase 1/2 study ongoing, initial clinical data expected in 3Q 2026 Cash balance of ...
Consolidated net revenue of € 713.4 million in the first quarter of 2026, +4.9% or +8.7% on a like-for-like basis(3) at constant exchange rates (CER); adverse FX impact of € 29.1 million (-4.3%)EBITDA ...
Armadillos are becoming increasingly common at Congaree National Park, and this guide explains how to safely avoid encounters ...
Its Safety Perception Index, developed with Ipsos, indicates improving user confidence as these features are introduced ...
It is a new category. A proprietary AI ecosystem built at the core of FCM's technology, making Sam the intelligence layer running through everything FCM does - not a feature sitti ...
Evolution Petroleum Corporation (NYSE American: EPM) ("Evolution" or the "Company") today announced its financial and operating results f ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results